Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in lean NAFLD
Ruohui Xu, Jiashu Pan, Wenjun Zhou, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113331-113331
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Early and accurate diagnosis of steatotic liver by artificial intelligence (AI)-supported ultrasonography
Sérgio Santoro, Mohamad Khalil, Hala Abdallah, et al.
European Journal of Internal Medicine (2024) Vol. 125, pp. 57-66
Closed Access | Times Cited: 10
Association between TyG index trajectory and new-onset lean NAFLD: a longitudinal study
Haoshuang Liu, Jingfeng Chen, Qian Qin, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 9
The relationship between serum uric acid level and non-alcoholic fatty liver disease in northern China: a retrospective cohort study
Qianjun He, Xinyue Liu, Guoyong Ding, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Soyeon Shin, Jaeyoung Kim, Ju‐Yeun Lee, et al.
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 4, pp. 289-302
Open Access | Times Cited: 22
Lean or diabetic subtypes predict increased all-cause and disease-specific mortality in metabolic-associated fatty liver disease
Goh Eun Chung, Su Jong Yu, Jeong‐Ju Yoo, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Association between weight-adjusted waist index and non-alcoholic fatty liver disease: a population-based study
Changhui Yu, Shiming He, Maobin Kuang, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus
Karina Sato-Espinoza, Perapa Chotiprasidhi, Mariella R. Huamán, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 3, pp. 452-464
Open Access | Times Cited: 7
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 658-658
Open Access | Times Cited: 24
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction–Associated Steatotic Liver Disease in Lean Individuals
Samuel J. Martínez‐Domínguez, Sandra G. García, Carla J. Gargallo-Puyuelo, et al.
Inflammatory Bowel Diseases (2023)
Open Access | Times Cited: 16
From NAFLD to MASLD: When metabolic comorbidity matters
Shan Hong, Lei Sun, Yiwei Hao, et al.
Annals of Hepatology (2023) Vol. 29, Iss. 2, pp. 101281-101281
Open Access | Times Cited: 14
Discovery of the First-in-Class Intestinal Restricted FXR and FABP1 Dual Modulator ZLY28 for the Treatment of Nonalcoholic Fatty Liver Disease
Qiang Ren, Ya Chen, Zongtao Zhou, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 9, pp. 6082-6104
Closed Access | Times Cited: 13
New aspects characterizing non-obese NAFLD by the analysis of the intestinal flora and metabolites using a mouse model
Wenji Zhang, Wenli Cheng, JingHui Li, et al.
mSystems (2024) Vol. 9, Iss. 3
Open Access | Times Cited: 6
A genetic mouse model of lean-NAFLD unveils sexual dimorphism in the liver-heart axis
Charlotte Burelle, Valentin Clapatiuc, Sonia Deschênes, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 5
Liver Steatosis is Prevalent in Lean People With HIV and Associated With Exposure to Antiretroviral Treatment—A Cross-sectional Study
Louise E. van Eekeren, Nadira Vadaq, W Vos, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 6
Open Access | Times Cited: 5
Eight Zhes Decoction ameliorates the lipid dysfunction of nonalcoholic fatty liver disease using integrated lipidomics, network pharmacology and pharmacokinetics
Yuping Zhou, Ze Dai, Kaili Deng, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 9, pp. 1058-1069
Open Access | Times Cited: 12
Comparison of MAFLD and NAFLD Characteristics in Children
Yunfei Xing, Jian‐Gao Fan, Haijun Wang, et al.
Children (2023) Vol. 10, Iss. 3, pp. 560-560
Open Access | Times Cited: 11
Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis and non-alcoholic fatty liver disease, 1990–2021: a multi-model trend analysis and forecasting study
Ti Yang, Lei Yang, Leyi Liao, et al.
Hepatology International (2025)
Closed Access
Differences in Fatty Acid Metabolism between MCDD and HFD Induced Metabolic Dysfunction-associated Fatty Liver Disease Model Mice
Jiaxuan Wang, Xinzhu Liu, Zhen Guo, et al.
Biological Procedures Online (2025) Vol. 27, Iss. 1
Open Access
The Interplay between Endocrine-Disrupting Chemicals and the Epigenome towards Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review
E. Nikolaou, Ioanna Panagiota Kalafati, George Dedoussis
Nutrients (2024) Vol. 16, Iss. 8, pp. 1124-1124
Open Access | Times Cited: 3
Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
Ιωάννα Αγγελετοπούλου, Maria Kalafateli, Efthymios P. Tsounis, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12864-12864
Open Access | Times Cited: 9
HOMA-IR is an effective biomarker of non-alcoholic fatty liver disease in non-diabetic population
Pei Zeng, Xiangsheng Cai, Xiaozhou Yu, et al.
Journal of International Medical Research (2023) Vol. 51, Iss. 10
Open Access | Times Cited: 9
Steatotic liver disease among lean and non-lean individuals in Southern Lao PDR: a cross-sectional study of risk factors
Anousin Homsana, Phonesavanh Southisavath, Kerstin Kling, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 3
Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm
Damien Chua, Zun Siong Low, Guo Xiang Cheam, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14762-14762
Open Access | Times Cited: 13
Metabolic-Associated Fatty Liver Disease and Diabetes
Nitin Kapoor, Sanjay Kalra
Endocrinology and Metabolism Clinics of North America (2023) Vol. 52, Iss. 3, pp. 469-484
Closed Access | Times Cited: 7
Role of BMI in the relationship between dietary inflammatory index and non-alcoholic fatty liver disease: an intermediary analysis
Liqiaona Fan, Songfeng Zhao, Haiyun Shi, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 58, Iss. 10, pp. 1159-1165
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top